CD8A and neoplasm: Next, using an identical experimental set-up to that used in the RNA-seq analysis, we treated B16F10 tumors with αCD45-Cyt or IgG-Cyt therapy and profiled p15E+CD8+ T cells in the tumor and TDLNs 24 h after IL-15 dosing by flow cytometry.